Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice.

Raleigh, David R; Chen, William C; Gondi, Vinai; Rogers, Leland; Mehta, Minesh.

Afiliação

Raleigh DR; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.
Chen WC; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.
Gondi V; Department of Pathology, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.
Rogers L; Departments of Radiation Oncology, Neurological Surgery, and Pathology, University of California San Francisco, Helen Diller Family Cancer Research Building 1450 3rd Street, HD481, 94158, San Francisco, CA, USA. david.raleigh@ucsf.edu.
Mehta M; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.

J Neurooncol ; 2024 May 14.

Article em En | MEDLINE | ID: mdl-38743346

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article